HomeCompareWSCC vs MRK

WSCC vs MRK: Dividend Comparison 2026

WSCC yields 181.82% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WSCC wins by $69.45M in total portfolio value
10 years
WSCC
WSCC
● Live price
181.82%
Share price
$1.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.51M
Annual income
$33,388,080.18
Full WSCC calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — WSCC vs MRK

📍 WSCC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWSCCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WSCC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WSCC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WSCC
Annual income on $10K today (after 15% tax)
$15,454.55/yr
After 10yr DRIP, annual income (after tax)
$28,379,868.15/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, WSCC beats the other by $28,371,271.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WSCC + MRK for your $10,000?

WSCC: 50%MRK: 50%
100% MRK50/50100% WSCC
Portfolio after 10yr
$34.78M
Annual income
$16,699,096.98/yr
Blended yield
48.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WSCC
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WSCC buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWSCCMRK
Forward yield181.82%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$69.51M$57.7K
Annual income after 10y$33,388,080.18$10,113.78
Total dividends collected$65.15M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WSCC vs MRK ($10,000, DRIP)

YearWSCC PortfolioWSCC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$28,882$18,181.82$11,213$373.04+$17.7KWSCC
2$79,981$49,077.01$12,667$512.06+$67.3KWSCC
3$212,594$127,014.75$14,439$708.14+$198.2KWSCC
4$543,003$315,527.24$16,640$988.16+$526.4KWSCC
5$1,334,202$753,189.45$19,432$1,394.07+$1.31MWSCC
6$3,157,175$1,729,577.94$23,057$1,992.90+$3.13MWSCC
7$7,203,193$3,825,015.79$27,889$2,894.79+$7.18MWSCC
8$15,863,391$8,155,975.05$34,518$4,286.29+$15.83MWSCC
9$33,760,443$16,786,614.57$43,912$6,494.35+$33.72MWSCC
10$69,511,754$33,388,080.18$57,714$10,113.78+$69.45MWSCC

WSCC vs MRK: Complete Analysis 2026

WSCCStock

Waterside Capital Corporation is no longer investing. It is a venture capital, and private equity firm specializing in investments in mezzanine debt for growth expansion; management buyouts; recapitalizations; leveraged buyouts; acquisitions; and working capital. The firm also provides bridge financing. It seeks to invest in small private and public companies and small middle market companies. The firm does not invest in start-ups, turnaround situations, oil or gas exploration, real estate development, and direct lending businesses. The firm prefers to invest in companies based in the Mid-Atlantic region and also invests in small businesses based in Richmond, Hampton Roads, Virginia, Washington D.C., North Carolina, and Maryland. The firm prefers to provide, with a more than five year term with flexible amortization, between $500,000 and $3 million as subordinate loans and between $1 million and $3 million as senior debt financing. It prefers to invest in companies that have annual revenues greater than $5 million. The firm co-invests in case of large investments and prefers to structure its investments as debt with attached warrants on common stock or as senior debts. The firm prefers equity participation when it provides subordinate loans and a collateral of assets while providing senior debt financing. Westside Capital Corporation was founded in 1993 and is based in Virginia Beach, Virginia.

Full WSCC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WSCC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WSCC vs SCHDWSCC vs JEPIWSCC vs OWSCC vs KOWSCC vs MAINWSCC vs JNJWSCC vs ABBVWSCC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.